Design, synthesis and antifungal evaluation of novel mandelic acid derivatives containing a 1,3,4-oxadiazothioether moiety

Chem Biol Drug Des. 2021 Jul;98(1):166-174. doi: 10.1111/cbdd.13861. Epub 2021 May 26.

Abstract

A series of novel mandelic acid derivatives containing a 1,3,4-oxadiazothioether moiety were designed and synthesized. Bioassay results showed that some target compounds exhibited certain antifungal activity against six kinds of pathogenic fungi in vitro. Among the compounds, the EC50 values of T41 against Gibberella saubinetii, Verticillium dahlia and Sclerotinia sclerotiorum were 31.0, 27.0 and 32.1 μg/ml, respectively, and the EC50 value of T14 against S. sclerotiorum was 14.7 μg/ml. The antifungal activity against the resistant fungus S. sclerotiorum indicated that this series of target compounds may have the similar action modes or sites as the commercialized succinate dehydrogenase inhibitor carboxin. A morphological study with fluorescence microscope demonstrated that T41 can significantly destroy the membrane integrity of G. saubinetii.

Keywords: 1,3,4-oxadiazothioether; antifungal activity; cross-resistant; mandelic acid derivatives; synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / pharmacology
  • Ascomycota / drug effects*
  • Carboxin / chemistry
  • Catalytic Domain
  • Drug Resistance
  • Humans
  • Mandelic Acids / chemical synthesis*
  • Mandelic Acids / pharmacology
  • Protein Binding
  • Structure-Activity Relationship
  • Succinate Dehydrogenase / metabolism
  • Sulfides / chemistry*

Substances

  • Antifungal Agents
  • Mandelic Acids
  • Sulfides
  • Carboxin
  • Succinate Dehydrogenase
  • mandelic acid

Supplementary concepts

  • Sclerotinia sclerotiorum